| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 155 | / | 2020 | ||||||||
| Date of issue: | 2020-12-23 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| The Board of Directors gave a mandate for negotiations for the sale of the shares owned by the Company in its subsidiaries "Veta Pharma" AD and "Aromania" AD | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sofia, Bulgaria, December 23, 2020 – According to the requirements of art. 100t of LPOS, “Sopharma” AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that the Board of Directors gave a mandate to the Executive director and the Procurator of the company to negotiate for the sale of the shares owned by “Sopharma” AD in its subsidiaries “Veta Pharma” AD and “Aromania” AD. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| 3JR_BD_Subsidiaries_sale_155_espi.pdf | The Board of Directors gave a mandate for negotiations for the sale of the shares owned by the Company in its subsidiaries "Veta Pharma" AD and "Aromania" AD | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2020-12-23 | Ognian Donev | Executive Director | |||
3JR_BD_Subsidiaries_sale_155_espi.pdf
